The Palmetto GBA Jurisdiction J Provider Contact Center (PCC) will be closed Monday, May 26, 2025, in observance of the Memorial Day holiday. Please note the webchat feature will be unavailable on this date. However, during this closure, providers can use Sage, Palmetto GBA's chat self-service tool.

COVID-19: Updated Vaccines for Children Ages 6 Months - 5 Years

Published 03/02/2023

On December 8, 2022, the FDA amended the emergency use authorizations of the updated (bivalent) Pfizer-BioNTech and Moderna COVID-19 vaccines to include use in children down to 6 months old. Your patients may know these as “updated COVID-19 vaccines”:

  • Pfizer-BioNTech: all patients 6 months – 4 years old. Get important prescribing information.
  • Moderna: all patients 6 months – 5 years old. Get important prescribing information.

Use 4 new CPT codes effective December 8, 2022:

  • Code 91316 for Moderna COVID-19 Vaccine, Bivalent Product:
    • Long descriptor: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, for intramuscular use
    • Short descriptor: SARSCOV2 VAC BVL 10MCG/0.2ML
  • Code 91317 for Pfizer-BioNTech COVID-19 Vaccine, Bivalent Product:
    • Long descriptor: Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use
    • Short descriptor: SARSCOV2 VAC BVL 3MCG/0.2ML
  • Code 0164A for Moderna COVID-19 Vaccine, Bivalent - Administration – Booster Dose:
    • Long descriptor: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, booster dose
    • Short descriptor: ADM SRSCV2 BVL 10MCG/0.2ML B
  • Code 0173A for Pfizer-BioNTech COVID-19 Vaccine, Bivalent - Administration – Third Dose:
    • Long descriptor: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, third dose
    • Short descriptor: ADM SARSCV2 BVL 3MCG/0.2ML 3

Visit the COVID-19 Vaccine Provider Toolkit for more information, and get the most current list of billing codes, payment allowances, and effective dates. Note: You may need to refresh your browser if you recently visited this webpage.


Was this article helpful?